Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8M Buy
18,517
+16,214
+704% +$10.8M ﹤0.01% 827
2026
Q1
$1.25M Buy
2,303
+1,038
+82% +$423K ﹤0.01% 1222
2025
Q4
$397K Buy
+1,265
New +$401K ﹤0.01% 1558
2025
Q2
Sell
-634
Closed -$83.2K 1667
2025
Q1
$83.2K Sell
634
-225
-26% -$31.4K ﹤0.01% 1768
2024
Q4
$118K Buy
859
+68
+9% +$9.34K ﹤0.01% 1775
2024
Q3
$80.2K Sell
791
-184
-19% -$14.6K ﹤0.01% 1797
2024
Q2
$71.4K Sell
975
-107
-10% -$7.01K ﹤0.01% 1750
2024
Q1
$54.6K Sell
1,082
-513
-32% -$24.1K ﹤0.01% 1835
2023
Q4
$74.7K Buy
1,595
+978
+159% +$44.6K ﹤0.01% 1830
2023
Q3
$28.1K Sell
617
-205
-25% -$8.47K ﹤0.01% 1906
2023
Q2
$32.4K Buy
+822
New +$33.3K ﹤0.01% 1934

Other funds holding AGX

Amundi's AGX Position: Q2 2026 in Review

Amundi increased its Argan (AGX) stake by 704% in Q2 2026, buying an estimated $10.8M and bringing the position to 18,517 shares worth $14.8M. The position accounts for ﹤0.01% of the portfolio, ranked #827.

Amundi first reported a position in AGX in Q2 2023 and has held it in 11 quarters since. 562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Amundi held 18,517 shares of Argan worth $14.8M as of Q2 2026.
  • Amundi bought 16,214 Argan shares in Q2 2026, an estimated $10.8M.
  • Argan made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #827 holding.
  • Amundi first reported a position in Argan in Q2 2023 and has held it in 11 quarters since.
  • 562 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.